Screener
Sanara MedTech Inc. SMTI Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Sanara MedTech Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Sanara MedTech Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 5:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001493152-26-037176
| Line item | 2026 / Three Months Ended June 30, | 2025 / Three Months Ended June 30, | 2026 / Six Months Ended June 30, | 2025 / Six Months Ended June 30, |
|---|---|---|---|---|
| Net Revenue | $28,136,757 | $25,804,252 | $55,935,291 | $49,238,348 |
| Cost of goods sold | 1,981,347 | 1,937,282 | 3,904,936 | 3,772,249 |
| Gross profit | 26,155,410 | 23,866,970 | 52,030,355 | 45,466,099 |
| Operating expenses | ||||
| Selling, general and administrative | 22,601,690 | 19,634,319 | 44,483,210 | 38,763,527 |
| Research and development | 1,154,232 | 1,056,796 | 1,913,824 | 2,007,155 |
| Depreciation and amortization | 619,111 | 688,546 | 1,206,363 | 1,382,578 |
| Total operating expenses | 24,375,033 | 21,379,661 | 47,603,397 | 42,153,260 |
Document
FAQ
- What is Sanara MedTech Inc.'s total revenue?
- Sanara MedTech Inc. (SMTI) reported total revenue of $28.14M in Q2 2026.
- How has Sanara MedTech Inc.'s total revenue changed year-over-year?
- Sanara MedTech Inc.'s total revenue increased by 9.0% year-over-year, from $25.8M to $28.14M.
- What is the long-term trend for Sanara MedTech Inc.'s total revenue?
- Over 4 years (2021 to 2025), Sanara MedTech Inc.'s total revenue has grown at a 35.7% compound annual growth rate (CAGR), from $30.42M to $103.12M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Sanara MedTech Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude